Miller Michael L, Roller Elizabeth E, Wu Xinyaun, Leece Barbara A, Goldmacher Victor S, Chari Ravi V J, Ojima Iwao
ImmunoGen, Inc., 128 Sidney Street, Cambridge, MA 02139, USA.
Bioorg Med Chem Lett. 2004 Aug 2;14(15):4079-82. doi: 10.1016/j.bmcl.2004.05.027.
The targeted delivery of taxoids, in the form of taxane-antibody immunoconjugates, requires the preparation of taxoids containing moieties suitable for their conjugation to monoclonal antibodies. A series of taxoids incorporating a disulfide-containing linker at various positions of the taxoid framework have been prepared to investigate the most suitable position for conjugation. A second series of taxoids modified at the C-2 position aimed at increasing the potency of these taxanes has also been prepared.